NCT05864261View on ClinicalTrials.gov

Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

August 28, 2023

Study Completion Date

August 28, 2023

Conditions

Renal Anemia

Interventions

DRUG

JT1801 60ug

JT1801, 60ug, IV injection

DRUG

NESP 60ug

NESP, 60ug, IV injection

Trial Locations (1)

101149

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Yi Fang

OTHER

NCT05864261 - Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers | Biotech Hunter | Biotech Hunter